Prelude Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Prelude Capital Management’s Portfolio RYTM Stock Details RYTM Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$728K	Buy
2024 Q2	–	Sell
2024 Q1	$464K	Sell
2023 Q4	$800K	Buy
2023 Q3	$376K	Buy
2019 Q3	–	Sell
2019 Q2	$8K	Buy